The researchers stressed that the risk of melanoma they found among erectile dysfunction drug takers was modest, and would translate to about seven additional cases of cancer per 100,000 men taking PDE5 inhibitors.
Chris Chapple, Secretary General of the European Association of Urology, said, "The findings are an interesting observation but more research is needed. This paper reports a previously unreported potential association. It's an interesting observation, but it should not be a trigger for any change in current clinical practice relating to the use of drugs for the treatment of erectile dysfunction such as Viagra and related compounds."
The research is published in the
Journal of the American Medical Association.
Source: AFP